Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Liane Dupont, Luke B. Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Sadie R. Hallett, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Thomas J. A. Maguire, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E. Dickenson, Rui Pedro Galao, Jose M. Jimenez-Guardeño, Neophytos Kouphou, Marie Jose Lista, Suzanne Pickering, Ana Maria Ortega-Prieto, Harry Wilson, Helena Winstone, Cassandra Fairhead, Jia Su, Gaia Nebbia, Rahul Batra, Stuart Neil, Manu Shankar-Hari, Jonathan D. Edgeworth, Michael H. Malim, Katie J. Doores
doi: https://doi.org/10.1101/2021.06.07.21258351
Liane Dupont
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Luke B. Snell
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Carl Graham
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Jeffrey Seow
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Blair Merrick
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Thomas Lechmere
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Sadie R. Hallett
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Themoula Charalampous
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Adela Alcolea-Medina
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Isabella Huettner
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Thomas J. A. Maguire
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Sam Acors
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Nathalia Almeida
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Daniel Cox
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Ruth E. Dickenson
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Rui Pedro Galao
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Jose M. Jimenez-Guardeño
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Neophytos Kouphou
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Marie Jose Lista
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Suzanne Pickering
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Ana Maria Ortega-Prieto
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Harry Wilson
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Helena Winstone
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Cassandra Fairhead
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Jia Su
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Gaia Nebbia
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Rahul Batra
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Stuart Neil
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Manu Shankar-Hari
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Jonathan D. Edgeworth
2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Michael H. Malim
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Katie J. Doores
1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Data Availability
Anonymised data was used in this study and is not available for distribution outside the host organisations.
Posted June 08, 2021.
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Liane Dupont, Luke B. Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Sadie R. Hallett, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Thomas J. A. Maguire, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E. Dickenson, Rui Pedro Galao, Jose M. Jimenez-Guardeño, Neophytos Kouphou, Marie Jose Lista, Suzanne Pickering, Ana Maria Ortega-Prieto, Harry Wilson, Helena Winstone, Cassandra Fairhead, Jia Su, Gaia Nebbia, Rahul Batra, Stuart Neil, Manu Shankar-Hari, Jonathan D. Edgeworth, Michael H. Malim, Katie J. Doores
medRxiv 2021.06.07.21258351; doi: https://doi.org/10.1101/2021.06.07.21258351
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Liane Dupont, Luke B. Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Sadie R. Hallett, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Thomas J. A. Maguire, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E. Dickenson, Rui Pedro Galao, Jose M. Jimenez-Guardeño, Neophytos Kouphou, Marie Jose Lista, Suzanne Pickering, Ana Maria Ortega-Prieto, Harry Wilson, Helena Winstone, Cassandra Fairhead, Jia Su, Gaia Nebbia, Rahul Batra, Stuart Neil, Manu Shankar-Hari, Jonathan D. Edgeworth, Michael H. Malim, Katie J. Doores
medRxiv 2021.06.07.21258351; doi: https://doi.org/10.1101/2021.06.07.21258351
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)